Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan

PURPOSE: Pegylated interferon (Peg-IFN)-based therapy is effective in treating chronic hepatitis B (CHB) and C (CHC) but frequently induces adverse events (AEs). This study was conducted to compare the incidence of Peg-IFN-based therapy-associated AEs in Taiwanese patients with CHB and CHC. METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yang, Jeng-Fu, Kao, Yi-Hui, Dai, Chia-Yen, Huang, Jee-Fu, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Hsieh, Ming-Yuh, Wang, Liang-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer-Verlag 2010
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2994613/
https://ncbi.nlm.nih.gov/pubmed/21286344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9208-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky